2004
DOI: 10.1002/ppul.70037
|View full text |Cite
|
Sign up to set email alerts
|

HFA inhalers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2007
2007

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Their active medical ingredients, ease of use, portability, and all other characteristics are not meaningfully different from those of the CFC MDIs. The HFA MDIs may even have superior technical characteristics leading to more effective and reliable delivery and use of some medical compounds and subsequently lower systemic side effects (Stein and Stefely, 2003;Koninck et al, 2004;Thongngarm et al, 2005).…”
Section: Introductionmentioning
confidence: 98%
“…Their active medical ingredients, ease of use, portability, and all other characteristics are not meaningfully different from those of the CFC MDIs. The HFA MDIs may even have superior technical characteristics leading to more effective and reliable delivery and use of some medical compounds and subsequently lower systemic side effects (Stein and Stefely, 2003;Koninck et al, 2004;Thongngarm et al, 2005).…”
Section: Introductionmentioning
confidence: 98%